Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 35,000 shares at $19.54 ($689K) on 2018-01-22, disclosed to the SEC on 2018-01-24.
Open-market sale of $689k CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.54 | 5,000 | $98K | 14.2% |
| 2 | $19.55 | 5,000 | $98K | 14.2% |
| 3 | $19.67 | 5,000 | $98K | 14.3% |
| 4 | $19.67 | 5,000 | $98K | 14.3% |
| 5 | $19.68 | 5,000 | $98K | 14.3% |
| 6 | $19.83 | 5,000 |
| $99K |
| 14.4% |
| 7 | $19.83 | 5,000 | $99K | 14.4% |
| Total | $19.68 avg | 35,000 | $689K | 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-19 | $580K | — | Filing → |